CSE: 2017-0301 - Reinstatement - Abattis Bioceuticals Corp. (ATT)
/EINPresswire.com/ -- TORONTO, ONTARIO--(Marketwired - Mar 3, 2017) - Effective immediately the shares of Abattis Bioceuticals Corp. will be reinstated for trading.
The Company has rectified the default situation that gave rise to the suspension.
Effective Date: March 3, 2017
Symbol: ATT
Canadian Securities Exchange (CSE)
Listings
(416) 367-7340
Listings@thecse.com
www.thecse.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
